About Cellipont Bioservices

Cellipont Bioservices is a cell therapy CDMO with more than 15 years’ experience in the development and small-to-large batch manufacturing of cell therapies.

Our leaders have played an instrumental role in shaping cell therapy development and manufacturing methods and technologies, and our technically-strong team has been recognized by customers and technology partners for its ability to productively grow challenging cells. Cellipont is driven to help our clients expand patient access to life-changing medicines through best-in-class development, analytical and manufacturing capabilities.

Cellipont services include the creation of master and working cell banks, analytical and process development, and manufacturing services for a range of clients from preclinical (research & development) to Phase I-II with near term Phase III to commercialization capabilities.

We have extensive experience in multiple product areas, including CAR-T, iNK, dendritic cell, & other novel cell therapy approaches.

Cellipont services include the creation of master and working cell banks, analytical and process development, and manufacturing services for a range of clients from preclinical (research & development) to Phase I-II with near term Phase III to commercialization capabilities.

We have extensive experience in multiple product areas, including CAR-T, iNK, dendritic cell, & other novel cell therapy approaches.

We are a growing company with a culture that is extremely responsive and customer-centric.

Cellipont Bioservices has very deep technical experience, including 18,000+ tissue samples and more than 1,800 primary cell cultures. With decades of experience at advanced therapy service companies large and small, our leadership team is guiding Cellipont Bioservices’ growth with deep knowledge of what it takes to succeed in this space.

Cellipont cell therapy scientists in lab

Cellipont Bioservices’ facilities and quality systems are GMP-compliant and we hold a California Food & Drug Branch manufacturing license.

Cellipont Bioservices is privately held. Our core investor, Great Point Partners, is a dedicated healthcare focused investment firm with an extensive track record in successfully building biologics services businesses.

With R&D and cGMP manufacturing facilities in San Diego and Houston, Cellipont is strategically located to serve patients and clients across North America.

History of the Cellipont Brand and Logo

The name Cellipont combines two concepts that are central to who we are as a company. “Cell” reflects our deep focus on cell therapy science, while “pont” (the latin root for “bridge”) symbolizes several dimensions of the role we fulfill for clients, patients, partners and employees.

We bridge our innovator clients with patients
We bridge technical excellence and personal service
For our team, we bridge personal passion with professional vocation.

About our Logo

Our logo represents the structural elements of a suspension bridge as derived from the physical elements of a DNA helix.

Because a mastery of microbiology is central to our scientific strength, and because client service is core to our organizational “DNA”, we feel this DNA-based “bridge” is a fitting symbol to represent our team.